Drugs Xagena
Investigational once-daily oral, direct factor Xa inhibitor, Edoxaban ( Lixiana ), was shown to be superior to Enoxaparin ( Lovenox ) in preventing venous thromboembolic ( VTE ) events in patients fol ...
Xarelto is a medicine that contains the active substance Rivaroxaban; it is used for the following in adults : to prevent venous thromboembolism ( VTE ) in patients who are undergoing surgery to repla ...
Eliquis is a medicine that contains the active substance Apixaban; it is used to prevent venous thromboembolism in adults following a hip or knee replacement operation.Eliquis is also used to prevent ...
Pradaxa is a medicine that contains the active substance Dabigatran etexilate; it is used to prevent the formation of blood clots in the veins in adults who have had an operation to replace a hip or k ...
MHRA ( Medicines and Healthcare Products Regulatory Agency ) previously advised that the contraindications for Dabigatran ( Pradaxa ) had been clarified to include a range of clinical conditions where ...
European Commission ( EC ) has approved oral anticoagulant Xarelto ( Rivaroxaban ) for the treatment of pulmonary embolism ( PE ) and the prevention of recurrent deep vein thrombosis ( DVT ) and pulmo ...
Eliquis ( Apixaban ) is an oral selective Factor Xa inhibitor. By inhibiting Factor Xa, a key blood clotting protein, Apixaban decreases thrombin generation and blood clot formation. Eliquis is ap ...
The FDA ( Food and Drug Administration ) has approved a Supplemental New Drug Application ( sNDA ) for Eliquis ( Apixaban ) for the treatment of deep vein thrombosis ( DVT ) and pulmonary embolism ( P ...
The European Committee for Medicinal Products for Human Use ( CHMP ) has recommended approval of Lixiana ( Edoxaban ), an oral, once-daily selective factor Xa inhibitor, for the prevention of stroke a ...
